Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors
Study Type: Other
Phase: N/A
NCTID: NCT03206450
Principal Investigator:
Keith August
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone: A Prospective Randomized Controlled Trial
Study Type: Treatment
Phase: III
NCTID: NCT03295981
Principal Investigator:
Kyle Sweeney
Single Person IND for the Use of TK216 in a patient with metastatic Ewing sarcoma
Study Type: Treatment
Phase: N/A
NCTID: NCT00000000
Principal Investigator:
Benjamin Powers
A Phase II Randomized Controlled Trial of Neoadjuvant Pembrolizumab with Radiotherapy and Adjuvant Pembrolizumab in Patients with High-Risk, Localized Soft Tissue Sarcoma of the Extremity
Study Type: Treatment
Phase: II
NCTID: NCT03092323
Principal Investigator:
Benjamin Powers
A Randomized Phase III Trial of Vinorelbine, Dactinomycin, and Cyclophosphamide VINO-AC Plus Maintenance Chemotherapy with Vinorelbine and Oral Cyclophosphamide VINO-CPO vs Vincristine, Dactinomycin and Cyclophosphamide VAC plus VINO-CPO Maintenance in Patients with High Risk Rhabdomyosarcoma HR-RMS
Study Type: Treatment
Phase: III
NCTID: NCT04994132
Principal Investigator:
Keith August
A Phase 2, Multicenter, Open-label Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Subjects With Relapsed/Refractory Rhabdomyosarcoma RMS, Non-rhabdomyosarcoma Soft Tissue Sarcoma NRSTS and Ewing Sarcoma EWS
Study Type: Treatment
Phase: II
NCTID: NCT03441360
Principal Investigator:
Kevin Ginn
Brightline-4: A Phase III open-label, single-arm, multi-center study to assess the safety and efficacy of brigimadlin BI 907828 treatment in patients with treatment-na�ve or pre-treated advanced dedifferentiated liposarcoma
Study Type: Treatment
Phase: III
NCTID: NCT06058793
Principal Investigator:
Benjamin Powers
A Randomized Phase III Study of Neoadjuvant Chemotherapy followed by Surgery versus Surgery Alone for Patients with High Risk Retroperitoneal Sarcoma STRASS2
Study Type: Treatment
Phase: III
NCTID: NCT04031677
Principal Investigator:
Luke Selby
A Phase II Study of Belinostat and SGI-110 Guadecitabine for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma
Study Type: Treatment
Phase: II
NCTID: NCT04340843
Principal Investigator:
Benjamin Powers
A Phase 2 Study of DS-8201a NSC 807708 in Adolescents, or Young Adults with Recurrent HER2+ Osteosarcoma
Study Type: Treatment
Phase: II
NCTID: NCT04616560
Principal Investigator:
Kevin Ginn